Yongzhong Sun

Medicine & Life Sciences

1. Mifepristone 100%
2. Misoprostol 99%
3. Spontaneous Abortion 80%
4. Placebos 49%
5. Randomized Controlled Trials 37%
6. Spironolactone 32%
7. Venous Thromboembolism 27%
8. Fathers 25%
9. Cost-Benefit Analysis 23%
10. Atrial Fibrillation 22%
11. Quality of Life 21%
12. Leisure Activities 18%
13. Vulnerable Populations 17%
14. Weights and Measures 16%
15. fibrin fragment D 15%
16. Overweight 15%
17. Weight Loss 14%
18. Confidence Intervals 12%
19. Minority Groups 11%
20. Hemorrhage 10%
21. Random Allocation 10%
22. Healthy Lifestyle 10%
23. Pediatric Obesity 9%
24. Gestational Sac 8%
25. Exercise 8%
26. Body Mass Index 8%
27. Therapeutics 8%
28. Sample Size 7%
29. Interviews 7%
30. Costs and Cost Analysis 7%
31. Recurrence 7%
32. Life Style 6%
33. Obesity 5%
34. Aptitude 5%
35. Biomedical Technology Assessment 5%